"Chinese medicine research and development of the court"
Project Profile
First, the purpose of the project

China is a traditional natural medicine, the sovereign power, in Chinese medicine is the world’s largest treasure house of natural medicine, Chinese medicine and Chinese palace is the quintessence of Chinese medicine by the Poly. The project aims to explore China’s pharmaceutical research in the court of the relative dominance of the accumulated years of outstanding achievements in scientific research, clinical practice with long-term accumulation of experience, an effective international industrial development, the quality of Chinese medicine into a scale To enter the international market and benefit the people of the world, at the same time for the country to create wealth, create profits for the enterprises.

The objective of the project
The base project will integrate the Chinese court on the top-class medical technology experts and civil and domestic funds, international investment institutions strong capital strength, assembly of the medical, pharmaceutical, testing, technology, production management and market planning, marketing Talents, the court fully engaged in traditional Chinese medicine (including health care products) series of market-oriented research and development, and strive to in a short period of time, a distinct features, with independent intellectual property rights, outstanding quality, unique image, in line with international drug test The court standard products, a result of an internationally famous brand of natural medicine, the occupation of the domestic market at the same time, to enter the international market (the developed varieties directory see annex IV).
Base will be in full accordance with the norms of modern business model for the establishment and integration, and establish a sound corporate governance mechanism and the core team equity incentive mechanism to ensure that investors and investment income security, while allowing the individual talents and the future of the enterprise Development tied up, happy to serve their personal talents and contributions of the enterprises.
Base companies from the very beginning aimed at the domestic or overseas listing of the established goals, and strive to in about three years time, the listed company to achieve the scale and standards, complete listing of the great cause. The company is confident that investors bring to the lucrative investment income to the state and local contributions to the huge amount of tax, to reflect the extraordinary value of the knowledge-based economy.
Third, the project’s background
1. Chinese medicine goes back to ancient times, which is the scientific treasure house of Chinese medicine in a bright pearl. With Western "medical treatment" concept of synthetic drugs and the limitations of the injury was revealed and more in-depth understanding of Chinese medicine, "prevention", "Comprehensive conditioning," the concept of reasonable and natural for the good of Are increasingly being accepted and respected by the people today, the Chinese medicine industry was recognized as China’s accession to the WTO the most international market potential and competitiveness of the development potential in the strategic industry. According to the World Health Organization predicted that the next five years, -10, global sales of traditional Chinese medicine 200 billion U.S. dollars -3000 100 million U.S. dollars.
2. However, at present, in China, due to lack of funds and technology, research and development mechanism backward, traditional Chinese medicine pharmaceutical equipment is only equivalent to developed countries on the level of the 1970s, many of Dan, pills, powder, tablet there are different standards, quality Instability and other issues, into the international market can be very few products. This gap, China’s natural biological traditional Chinese medicine the country’s sovereign status has already posed a serious threat. In the pharmaceutical industry depends on the development of new drugs in the research and development and to create a independent intellectual property rights, the distinct features of the world’s famous brand of natural medicine on a major breakthrough, to a large extent dependent on the resources of industry consolidation and development of high-end models The innovation, and to accurately identify the breakthrough point.
3. Chinese medicine is in the court of the essence of traditional Chinese medicine. China’s history of the palace, Hui set a large number of talents in Chinese medicine, in extremely harsh conditions for the diagnosis and treatment of Dili Hou Fei Ping, engaged in medical practice, thereby making the court best blend of traditional Chinese medicine. Compatibility with exquisite palace medicine, excellent choice of materials, production of stringent and effective notable feature of its health Yan, Jiao beauty of the effectiveness of sales numbers unique, but not long-term hidden Gongjin rumored but little-known secret, Is that we inherit and carry forward the fine traditional Chinese medicine heritage of a very important component of Chinese medicine in China also have formed their own intellectual property rights, the distinct features of the natural world-renowned brand of hope for the drug.
China’s palace in the study of Chinese medicine, Chinese medicine China’s scientific community has no foreign scientific research institutions are unparalleled dominance, in the absolute leader. At the national leaders of the older generation visionary support to Chen Keji academicians as the representative of Chinese medicine experts in China since 1980, finishing with great concentration on the study by the National Palace Museum collection rich in the integrity of the court admitted the Royal Hospital, Dili After treatment at the end of the first-hand books, and other precious treasures palace medicine, more than 20 years, has made fruitful achievements in scientific research, has published numerous academic work. These research results have yet to be developed into a scale applications, a huge savings potential of the industry. Therefore, the focus of research and development of the Chinese palace authentic Chinese medicine remedies for industrial development, meaning huge, unlimited business opportunities.
4.2006, March 5, Chinese Premier Wen Jiabao at the Fourth Session of the Tenth National People’s Congress on the government work report, when it comes to gradually solve the difficult medical treatment, a doctor of your question, said: "To support the development of Chinese medicine, Give full play to prevent and cure diseases of Chinese medicine in the important role of "stress of Chinese medicine in China’s medical cause of the role and status, reflecting China’s national leader of the Chinese medicine attaches great importance to and support the attitude, is the revitalization of the Chinese Medicine A good opportunity, we must fully grasp. In the current in-depth development of China’s reform and development of the situation, the development of this industry the most efficient model, in certain countries under the policy of support to the operation of the market means, the high-end scientific research and civil funds, Overseas capital and other resources organically combined.
Third, the project based on the strengths and
1. The project’s greatest advantage lies in talent (see Annex 1): Chinese medicine research by the Chinese court’s chief scientist, Chinese Academy of Sciences Professor Chen Keji team the lead in the foundation, the Chinese top-level gathering of Chinese medicine and Chinese medicine The technology industry authority, its composition is difficult to challenge the technological superiority.
Chen Keji academicians, Professor Zhou Wenquan are the most authoritative court of domestic medicine experts; Professor Xie Peishan is China’s inspection and quality standards of Chinese medicine on the authority of traditional Chinese medicine in China is by fingerprint of the advocates and academic leaders; Zhu Chengwei, Senior Engineer of China’s long-renowned pharmaceutical production and technology experts, they are all national Pharmacopoeia Commission assessment of new drugs or members of the Committee, and Miss Zhang Guiying Zhuhai City is well-known Chinese medicine practitioners, Chinese medicine in the clinical application of the court has a secret recipe A wealth of experience, have been invited for the diagnosis and treatment of more than national leaders.
These experts are the sponsors of the base project, the project company are the establishment of committees, and the direct leadership and guidance to base the research and development projects.
2. The base project will be "good Zhuhai City singular Pharmaceutical Co., Ltd." as a platform to integrate resources from all sources form (Company Profile see annex III).
Qi Jia medicine was established in 2001, in Zhuhai City, the Bay Area has 30,000 square meters of industrial land, has been completed and an industrial plant (through the national drug and food GMP two-factor authentication), a pharmaceutical and health food production enterprises of all Qualifications.
Qi Jia medicine current main products of Chinese medicine for the pure blood pressure-lowering drug OTC "clock SHU Ping" (State Yao Zhunzi B20020775). Since the production of the product, because the exact effect, non-toxic side effects, much respected medical experts and patients welcomed the 2000 International Exposition of Chinese medicine was awarded the International Gold Award, 2001 by the U.S. FDA-certified plant products.
3. Qi Jia’s mother’s body medicine "Zhuhai Institute of Traditional Medicine", was founded in 1987, the academician Chen Keji on the initiative of the establishment of China’s first private medical research institutions, three under clinical observation Clinics, the last 20 years, has focused on traditional Chinese palace and the ancient secrets of the development and validation of clinical research, clinical application of a secret court and the development of the rich practical experience.
4. Qi Jia Pharmaceutical and Medical Research Institute are now Miss Zhang Guiying family-owned, shareholding structure is simple, clear property rights relations and easy to carry out shareholding reform.
Fourth, the project company’s basic structure, ownership structure and financing plan
1. Base for the project company will be called "The court pharmaceutical R & D Co., Ltd. of China" (English name: China Royal Medicine R & D Institute)
2. Initial registered capital of the company for the renminbi (or HK) 3 10 million yuan, with a total investment 8 10 million yuan, to be surprising to pharmaceutical companies for better integration of existing resources base, and further promote the special-projects registered in Hong Kong "China Court Pharmaceutical Group Co., Ltd. "---- joining the joint-venture investment partners at home and abroad, to Hong Kong through the" China Pharmaceutical Group of the court "investment, capital injection by the laws of Hong Kong jurisdiction and protection. Hong Kong, "China Pharmaceutical Group of the court" and Zhuhai, "the court pharmaceutical research and development companies in China," cross-shareholding, namely:

The base project is a follow established international, the Group of the road of development policy, investment-oriented at home and abroad, invites the tremendous business opportunities in this keen sense and foresight of the investors joining, and seek common development, sharing of results. Welcomed the intention to invest in China’s pharmaceutical industry entrepreneurs and strategic investors to contact with our contacts, and discuss cooperation plans. Lines need to, open up ideas, not welcome.

Annex 1: academic experts

Court medical care, since ancient times because of deep layer of mystery over the palace, Qixiao colors, from family history of medicine and Zhuichong. After the liberation, in order to make the court Micang medicine for the Chinese side to clinical services, the state assigned to Professor Chen Keji, led by the Panel of Experts, after 16 years, the palace clock in history, Dihou medication at the end of thin, Jingshi the files, Neiwu Fu transcripts, the emperor Zhupi systems such as the collation and has prepared and published writings, "the Chinese palace medicine", "the court Micang medical history, the book", "Medical Research Qinggong" Shi Yubu monographs. These studies documented the palace and the Yuyi medical diagnostic techniques used so far have not been integrated clinical practice, the Chinese city of Zhuhai City health Yuyi Court of traditional medicine and medical characteristics of the court, the academician Chen Keji began to organize the proposed .

Deng Tietao Guangzhou University of Traditional Chinese Medicine, Professor doctoral tutor
State Administration of Traditional Chinese Medicine incumbent member of the expert,
Life-long contribution to the state special allowances experts, several Senate
National institutions of higher learning and large increases in the preparation of medicine, Chinese medicine professionals in more than 20 Division. Is the first generation since the founding of the outstanding medical experts, traditional medicine has always been advocating innovative ideas. 2003 during the SARS spread of the virus, a letter to the old Deng, made use of Chinese medicine and immunology theory of the SARS virus and provided excellent technical guidance, the international academic community and attaches great importance to the central, Guangdong because of the first sector to Chinese medicine treatment has been made The best results can be described as "Zhangong prominent."

Professor Zhang Dazhao (born in Hong Kong)
Former president of the Guangzhou Overseas Chinese Hospital, will return to Hong Kong in 1991
Habitat. Many times in various foreign languages to participate in the summit and a doctor
Chinese international academic seminars, to promote and revitalize the Chinese have made outstanding contributions. That is, the handover of the Hong Kong, Macao, Taiwan and the mainland academic exchanges played a positive role.
Hong Kong Chief Executive Tung Chee-hwa appointed Professor Zhang Dazhao for the development of Chinese medicine in Hong Kong, June 29, 1997 to accept Prince Charles awarded the MBE honours the Queen, in recognition of his achievements in medicine, this is Hong Kong Chinese-win The first person.

Professor Zhou Wenquan, doctoral tutor
China Research Institute of Chinese Medicine Research Center Director of the elderly, the Chinese Research Institute of Traditional Chinese Medicine Qinggong Medical Research Office, the Chinese Medicinal Diet
Institute of the Ministry of Health national director of the Center for medical examinations, member countries Pharmacopoeia Committee members, appointed by the Central Bureau of health care doctors. Professor Chen Keji and organize joint research in the court admitted 16, is chief of China’s elderly medical research experts.

Professor Luo Zhiqiang, doctoral tutor
Zhongshan Medical University, the first leg of Chinese medicine hospital medical director,
Medical basic theoretical research director, Chinese medicine treatment of cardiovascular and cerebrovascular
Disease experts, papers over 80 articles, editor of the University "medical" teaching materials; editor of "Chinese medicine treatment since the series" a total of eight, won the International Center for scientific research, the research work of Chinese medicine in more than 40 years, "桃李满天下" Chinese culture to numerous outstanding students, particularly in Hong Kong, Macao, and Taiwan very much affected, as have many of Hong Kong, Macao and Taiwan studying Chinese medicine in general classes to teach.

Management experts

Modernization of Traditional Chinese Medicine Research preparations staff

Professor Xie Peishan Guangzhou Port of Drug Control Officer, engaged in traditional Chinese medicine test And quality standard of 47, have contributed more to China by Chinese medicine fingerprint of the advocates and academic leaders. States Pharmacopoeia Committee, the review of new drugs and quality standards accreditation experts, the Chinese medicine variety protection review committee members, has since 1992 been enjoying a special contribution to national experts allowance. Special allowances.

Zhu Chengwei, Senior Engineer
Former chief engineer of the Shanghai Traditional Chinese Medicine a plant, development of the 1970s to produce the first injection of Chinese medicine "Xiaochaihu injection" and well-known international pharmaceutical industry. China’s Modernization of Traditional Chinese Medicine for the excellent step forward, was elected the first session of the General Assembly on behalf of the National Science and Technology, is a famous Chinese expert of Chinese medicine, the Ministry of Health review of new drugs, member of National Committee of Experts on new drug research and development, member countries Pharmacopoeia Committee.

Units for launch